U of S | Mailing List Archive | Circulatory_respiratory-l | Knowledge to Action - Clinical Interventions for Cardiovascular Diseas

Knowledge to Action - Clinical Interventions for Cardiovascular Disease


  • To: "circulatory_respiratory-l@usask.ca" <circulatory_respiratory-l@usask.ca>
  • Subject: Knowledge to Action - Clinical Interventions for Cardiovascular Disease
  • From: "Boyko, Sonia" <sonia.boyko@usask.ca>
  • Date: Tue, 28 Jun 2011 09:15:09 -0600
  • Accept-language: en-US
  • Acceptlanguage: en-US
  • Comments: Circulatory and Respiratory Health (ICRH)
  • Delivered-to: circulatory_respiratory-archive@www.usask.ca
  • In-reply-to: <4B33A1DEF487084AB2B6E41366B83A7C037F29B5C8@OUTBACK2.usask.ca>
  • References: <4B33A1DEF487084AB2B6E41366B83A7C037F29B5C8@OUTBACK2.usask.ca>
  • Thread-index: Acw1oQfb9M/gXklkTWSNCRmE+kn3+gABIMQQ
  • Thread-topic: Knowledge to Action - Clinical Interventions for CardiovascularDisease

Title: May Announcement

 

Clinical Interventions for Cardiovascular Disease: Enhancing Effectiveness (Operating Grant: Knowledge to Action - Fall 2011 Priority Announcement)

The CIHR Institute of Gender and Health's (IGH) Clinical Interventions for Cardiovascular Disease (CVD) initiative addresses the need for clinical interventions that are accessible, appropriate and effective with respect to sex and gender. CVD (including coronary artery disease, angina, congestive heart failure, hypertension and stroke) is the major cause of death and disability worldwide. Taking account of sex and gender has the potential to improve strategies for preventing, detecting and treating CVD. There is therefore a need to find ways to mobilize ready-to-implement evidence about sex and gender in the prevention, diagnosis and treatment of CVD to improve clinical practices.

IGH will provide funding for successful applications that are determined to be relevant to one or more of the following priority areas:
o Bridge a knowledge-to-action gap specific to gender, sex and clinical interventions for CVD.
o Accelerate the uptake of gender, sex and CVD research evidence into clinical practice.
o Enhance the effectiveness of clinical interventions for CVD by taking sex and gender into account.

For more information on IGH's strategic research direction on clinical interventions: enhancing effectiveness, please see IGH's Strategic Plan 2009-2012: http://www.cihr-irsc.gc.ca/e/38770.html

Funds Available
• The total amount available for this funding opportunity is $ 600,000. This amount may increase if additional funding partners decide to participate.
• The maximum amount awarded for a single grant is $ 100 000 per annum for up to two (2) years.

Specific Requirements
• This Priority Announcement will require the completion of a Relevance Form.
• Applicants are strongly encouraged to align their relevance form with their one-page project summary. The relevance form and one-page project summaries must clearly articulate how the concepts of gender and/or sex are integrated into the respective research designs and approaches. It is not sufficient simply to cite literature explaining why a study relates to gender and/or sex; these concepts must be substantively integrated into the research design. For more information on integrating gender and/or sex into research designs, please refer to the CIHR Gender, Sex and Health Research Guide: http://www.cihr-irsc.gc.ca/e/32019.html

ResearchNet: http://www.researchnet-recherchenet.ca/rnr16/vwOpprtntyDtls.do?prog=1316&&view=currentOpps&org=CIHR&type=AND&resultCount=25&sort=program&all=1&masterList=true#ci

Important Dates
Competition: 201110KAL 
Application Deadline: 2011-10-03   
Anticipated Notice of Decision: 2012-04-02   
Funding Start Date: 2012-04-01


Have a success story to share? IGH welcomes contributions to its biannual newsletter Intersections. The goal of Intersections is to showcase the best of Canadian gender, sex, and health research and to highlight how this research is improving health. Please contact ea-igh@exchange.ubc.ca to submit your ideas or to request further information.


****************************************************************************************************************